Evidence map›Paper›PMID 41000718›Full record

ArticlebioRxiv : the preprint server for biology2025

Biochemical characterizations of Pontocerebellar Hypoplasia linked mutations of Target of Egr1 (TOE1) reveal impacts on thermal stability, ribonuclease activity, and oligomerization.

Lizette Zavala, Magdalena Sobien, Cassandra K Hayne

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Lizette ZavalaDepartment of Biochemistry and Molecular Biology, University of Chicago, Chicago, Illinois, 60637, USA.ORCID 0000-0002-5526-3081
Magdalena SobienDepartment of Biochemistry and Molecular Biology, University of Chicago, Chicago, Illinois, 60637, USA.ORCID 0000-0001-5217-5433
Cassandra K HayneDepartment of Biochemistry and Molecular Biology, University of Chicago, Chicago, Illinois, 60637, USA.ORCID 0000-0002-2485-5949

Funding

University of Chicago Initiative for Maximizing Student Development (IMSD) - Renewal 01R25GM109439 · NIGMS · UNIVERSITY OF CHICAGO · PI SCHWARTZ, NANCY B · 2014 to 2023
$5.7M
Predoctoral Training Program in Chemistry and BiologyT32GM144290 · NIGMS · UNIVERSITY OF CHICAGO · PI Yamuna Krishnan, Joseph Anthony Piccirilli · 2022 to 2026
$1.6M
Structural and Functional Characterization of Pontocerebellar Hypoplasia Associated NucleasesR00GM143534 · NIGMS · UNIVERSITY OF CHICAGO · PI HAYNE, CASSANDRA K · 2023 to 2025
$800k
NIGMS NIH HHS R00 GM143534NIGMS NIH HHS R25 GM109439NIGMS NIH HHS T32 GM144290
6 · The paper itself

Abstract

The Target of EGR1 (TOE1) gene encodes the TOE1 deadenylase, which is essential for the maturation of Pol-II transcribed snRNAs in humans. Over a dozen missense mutations in the TOE1 gene have been linked to Pontocerebellar Hypoplasia Type 7 (PCH7), a rare but serious neurodevelopmental and neurodegenerative disease that leads to early mortality. The biochemical mechanisms for why these PCH7-linked mutations alter TOE1's biochemical characteristics remains vague. Here, we utilized AlphaFold predicted structures of TOE1 and biochemical characterizations to investigate the impact of TOE1 variants on TOE1's biochemical properties. We performed characterization of the thermal stability and activity of eleven PCH-linked TOE1 variants and found that eight variants have significant reduced protein thermal stability and only two variants impair TOE1's ribonuclease activity, particularly its exonuclease activity. Additionally, we found that the F148Y mutation impacts TOE1's oligomeric state

Identifiers

PMID41000718
PMCPMC12458952

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.